Who backs Rgenta Therapeutics?
13 investors| Investor | Type |
|---|---|
| Korea Investment Partners | Venture capital |
| CICC Capital | PE / buyout |
| Legend Star | Venture capital |
| EQT Ventures | Venture capital |
| Vivo Capital | Venture capital |
| Boehringer Ingelheim Venture Fund | Other |
| AstraZeneca | — |
| Delos Capital Partners | — |
| Kaitai Capital | — |
| LAV (Lilly Asia Fund) | — |
| + 3 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Rgenta Therapeutics investors
13 investors are on record for Rgenta Therapeutics, including Korea Investment Partners, CICC Capital, Legend Star and EQT Ventures. By type, the record holds 4 venture capital firms and 1 private equity firm. The early-stage round in Nov 2021 drew 6 investors.
Free account
More of Rgenta Therapeutics with a free account
- ·The complete investor list: 13 names
- ·Watch Rgenta Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 13 firms already write checks for companies like Rgenta Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View